Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bushen Zhuyun Recipe vs Femoston for recurrent miscarriage with thin endometrium
ChiCTR2200061644Phase 2Not yet recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Bushen Zhuyun in recurrent miscarriage (RPL) and Endometrial hypotrophy (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Early pregnancy outcome and Endometrial thickness and type changes. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
Bushen Zhuyun
03
Conditions
recurrent miscarriage (RPL)Endometrial hypotrophy
Beyond the preview
Go deeper on ChiCTR2200061644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061644.